Designation
.gif){kind=small}
Information about pandemic influenza vaccinesИнформация относно ваксини за пандемичен грипInformación sobre vacunas contra la pandemia gripal Informace o vakcínách proti pandemické chřipce Information om vacciner mod pandemisk influenza Informationen über Impfstoffe gegen pandemische Influenza Teave pandeemiliste gripivaktsiinide kohta Πληροφορίες για τα εμβόλια της πανδημικής γρίπης Informations sur les vaccins contre la grippe pandémiqueInformazioni sui vaccini per l’influenza pandemica Informācija par gripas pandēmijas vakcīnām Informacija apie vakcinas nuo pandeminio gripo Világméretű influenzajárvány elleni vakcinákra vonatkozó információk Informazzjoni dwar il-vaċċini għall-influwenza pandemika Informatie over vaccins tegen pandemische griep Informacje o szczepionkach przeciw grypie pandemicznej Informação sobre vacinas contra a pandemia da gripe Informaţii despre vaccinurile gripale pandemice Informácie o očkovacích látkach proti pandemickej chrípke Informacije o cepivih proti pandemični gripi Tietoa influenssapandemian aikana käytettävistä rokotteista Information
om vacciner mot pandemisk influensa
|
| European Medicines Agency and Swissmedic agree sharing of information on H1N1 pandemic medicines |
Published 15/02/2010 |
The European Medicines Agency and Swissmedic will from now on be able to exchange confidential information about the authorisation and safety of medicines used in the context of the H1N1 pandemic influenza. The confidentiality arrangement was agreed between the European Medicines Agency and the Swiss Agency for Therapeutic Products, Swissmedic, on 12 February 2010. |
| New presentation of monthly figures on centralised procedures for human medicines |
Published 08/02/2010 |
The European Medicines Agency has started publishing monthly figures related to the centralised procedure activities for human medicines in a new way. These monthly figures will provide current information related to the volume and evaluation of marketing authorisation and post-authorisation applications for medicinal products for human use received by the European Medicines Agency. They are complementary to the CHMP monthly report and will be published on the Agency’s website within two weeks following the end of the CHMP meeting. |
| The European Medicines Agency marks its 15th anniversary with a short film |
Published 26/01/2010 |
Inaugurated on 26 January 1995, the European Medicines Agency has now been working with its partners in the EU Member States to promote and protect human and animal health across the European Union for 15 years. As part of its 15th anniversary celebrations, the Agency has commissioned a short film that provides a flavour of the ever-evolving environment in which it operates. |
Watch the 5-minute film (30MB |
| Latest Press Releases | See Press Office for archived press releases |
|
| 26/02/10 | COMP | FDA and EMA Agree to Accept a Single Orphan Drug Designation Annual Report |
| 19/02/10 | EMA | United Therapeutics Europe Ltd withdraws its marketing authorisation application for Tyvaso |
| 19/02/10 | CHMP | Press Release from the CHMP February meeting |
| 19/02/10 | EMA | European Medicines Agency updates on pandemic influenza |
| 18/02/10 | EMA | European Medicines Agency recommends contraindication for Regranex in patients with any pre-existing cancer - See also: Questions and Answers |
| 16/02/10 | EMA | European Medicines Agency and EUnetHTA Joint Action start collaboration on European Public Assessment Report (EPAR) contribution to relative effectiveness assessments |
| 15/02/10 | EMA | European Medicines Agency and Swissmedic agree sharing of information on H1N1 pandemic medicines |
See Press Office for archived press releases |
||